Clinical trial with the levonorgestrel intrauterine system to measure changes in hemoglobin and serum ferritin among anemic women in Kenya

使用左炔诺孕酮宫内节育系统测量肯尼亚贫血妇女血红蛋白和血清铁蛋白变化的临床试验

基本信息

  • 批准号:
    10221015
  • 负责人:
  • 金额:
    $ 51.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Anemia continues to disproportionately affect marginalized women in resource-poor countries. In Africa/SE Asia, over 270 million women of reproductive age are anemic. Iron deficiency anemia causes 18% of maternal deaths worldwide. Multiprong approaches are needed to reduce the prevalence of anemia and the negative impact on family health. Every menstrual cycle, women lose 14 to 19 mg of iron; this is iron that anemic women need to lead healthier lives. Though the relationships between iron loss from menstruation, absorption of dietary intake of iron, storing iron, and the impacts on hematologic parameters are complex, higher levels of menstrual blood loss are associated with lower hemoglobin values. The levonorgestrel intrauterine system is a highly effective contraceptive product that also generally reduces menstrual blood loss. In research spanning over four decades, the product consistently raises hemoglobin levels and increases iron stores in broad populations of women, but particularly for women with heavy menstrual bleeding. This product is not widely available in resource-poor countries, due to higher costs relative to other contraceptives. As a potential tool to alleviate anemia, the levonorgestrel intrauterine system has never been adequately tested. Previous research has never focused on anemic women, nor used proper scientific approaches to determine if the product can significantly increase hemoglobin and iron levels via reducing menstrual blood loss. The overall goal of the proposed research is to give anemic women in Kenya an opportunity to try the levonorgestrel intrauterine system and with improved scientific approaches, measure the impact on hemoglobin and iron stores. In this randomized trial, the comparison product will be oral contraceptives containing iron supplement pills, which are widely available and used in Kenya. If the levonorgestrel intrauterine system is found to work as hypothesized, then the product can become another tool to alleviate anemia among reproductive-aged women, resulting in healthier living and healthier beginnings to pregnancy when desired.
项目摘要/摘要 贫血症继续对资源贫乏国家的边缘化妇女造成不成比例的影响。在……里面 在非洲/东南亚,超过2.7亿育龄妇女患有贫血症。缺铁性贫血导致 占全球孕产妇死亡的18%。需要采取多管齐下的方法来降低贫血率。 以及对家庭健康的负面影响。 在每个月经周期,女性会失去14到19毫克的铁;这是贫血女性需要摄入的铁 更健康的生活。经期铁丢失与膳食摄入量之间的关系 对铁的影响,储存铁,对血液学参数的影响是复杂的,月经水平较高 失血与较低的血红蛋白值有关。 左炔诺孕酮宫内系统是一种高效的避孕产品,一般情况下 减少月经失血。在40多年的研究中,该产品不断提高 在广泛的女性人群中,血红蛋白水平和铁储存增加,尤其是对患有 月经大出血。这种产品在资源贫乏的国家并不普遍,因为价格较高 相对于其他避孕药具的成本。 作为一种潜在的缓解贫血的工具,左旋诺孕酮宫内系统从未被 经过充分测试。以前的研究从来没有关注过贫血女性,也没有使用过适当的科学方法 确定该产品是否可以通过降低血红蛋白和铁含量显著提高水平的方法 月经失血。 这项拟议研究的总体目标是让肯尼亚的贫血妇女有机会尝试 左旋诺孕酮宫内系统,并通过改进的科学方法,测量对 储存血红蛋白和铁。在这项随机试验中,比较产品将是口服避孕药 含有补铁药丸,在肯尼亚广泛使用。如果左旋诺孕酮 宫内系统被发现如假设的那样工作,那么该产品可以成为另一种缓解 育龄妇女中的贫血,导致更健康的生活和更健康的怀孕初期 在需要的时候。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID HUBACHER其他文献

DAVID HUBACHER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID HUBACHER', 18)}}的其他基金

Clinical trial with the levonorgestrel intrauterine system to measure changes in hemoglobin and serum ferritin among anemic women in Kenya
使用左炔诺孕酮宫内节育系统测量肯尼亚贫血妇女血红蛋白和血清铁蛋白变化的临床试验
  • 批准号:
    10688071
  • 财政年份:
    2020
  • 资助金额:
    $ 51.31万
  • 项目类别:
Clinical trial with the levonorgestrel intrauterine system to measure changes in hemoglobin and serum ferritin among anemic women in Kenya
使用左炔诺孕酮宫内节育系统测量肯尼亚贫血妇女血红蛋白和血清铁蛋白变化的临床试验
  • 批准号:
    10456074
  • 财政年份:
    2020
  • 资助金额:
    $ 51.31万
  • 项目类别:
Long-acting Reversible Contraception: New Research to Reduce Unintended Pregnancy
长效可逆避孕:减少意外怀孕的新研究
  • 批准号:
    8466245
  • 财政年份:
    2011
  • 资助金额:
    $ 51.31万
  • 项目类别:
Long-acting Reversible Contraception: New Research to Reduce Unintended Pregnancy
长效可逆避孕:减少意外怀孕的新研究
  • 批准号:
    8027074
  • 财政年份:
    2011
  • 资助金额:
    $ 51.31万
  • 项目类别:
Long-acting Reversible Contraception: New Research to Reduce Unintended Pregnancy
长效可逆避孕:减少意外怀孕的新研究
  • 批准号:
    8242101
  • 财政年份:
    2011
  • 资助金额:
    $ 51.31万
  • 项目类别:
Prophylactic Ibuprofen: Effect on IUD Continuation Rates
预防性布洛芬:对宫内节育器继续使用率的影响
  • 批准号:
    6526411
  • 财政年份:
    2001
  • 资助金额:
    $ 51.31万
  • 项目类别:
Prophylactic Ibuprofen: Effect on IUD Continuation Rates
预防性布洛芬:对宫内节育器继续使用率的影响
  • 批准号:
    6655712
  • 财政年份:
    2001
  • 资助金额:
    $ 51.31万
  • 项目类别:
Prophylactic Ibuprofen: Effect on IUD Continuation Rates
预防性布洛芬:对宫内节育器继续使用率的影响
  • 批准号:
    6370608
  • 财政年份:
    2001
  • 资助金额:
    $ 51.31万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了